Physician profile
Jay Basillote
NPI 1245202555
$4,399.85
in general payments reported to CMS, 2019-2025
28 companies · $1,019 in 2025
The $1,019 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $566 · 2020: $146 · 2021: $441 · 2022: $745 · 2023: $853 · 2024: $630 · 2025: $1,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,122 · Education: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,121.67 |
| Education | $380.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $849.08 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Astellas Pharma US INC | $838.34 | 2019-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $403.79 | 2020-2025 | |
| Axonics, INC. | $269.19 | 2022-2024 | Axonics, Bulkamid |
| Merck Sharp & Dohme LLC | $211.75 | 2020-2025 | Keytruda, Lynparza |
| Sumitomo Pharma America, INC. | $193.83 | 2023-2025 | Orgovyx, Gemtesa |
| 180 Medical, INC. | $160.96 | 2019-2025 | Cure Catheter |
| Olympus America INC. | $130.96 | 2024-2025 | Itind System |
| Emd Serono, INC. | $123.94 | 2022 | |
| Ge Healthcare | $122.04 | 2023 | |
| Accord Healthcare, INC. | $118.62 | 2022-2024 | |
| Myovant Sciences INC. | $117.93 | 2021-2022 | |
| Pfizer INC. | $113.49 | 2019-2025 | |
| Bluewind Medical | $89.70 | 2025 | |
| Boston Scientific Corporation | $83.81 | 2019-2025 | Axonics, Rezum Generator |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $81.87 | 2022 | |
| Seagen INC. | $78.99 | 2025 | |
| Teleflex LLC | $76.95 | 2023-2024 | Urolift |
| Antares Pharma, INC. | $64.25 | 2022-2025 | Xyosted |
| C. R. Bard, INC. & Subsidiaries | $49.14 | 2019 | |
| Becton, Dickinson and Company | $41.12 | 2022 | |
| Endo Pharmaceuticals INC. | $35.46 | 2019 | |
| Urovant Sciences INC | $33.35 | 2022 | |
| Rochester Medical Corporation | $27.13 | 2019-2020 | |
| Procept Biorobotics Corporation | $26.23 | 2024 | Aquabeam System |
| Ambu INC. | $22.05 | 2021 | |
| Dentsply Ih Ab | $19.27 | 2021 | |
| Dentsply Ih INC. | $16.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Basillote listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.